Crovalimab
- Biologic
- Piasky
Therapy management checklist
Screening, baseline and ongoing monitoring with the label's stated frequency, hold and discontinue criteria, and counseling points, each quoted from the FDA label.
Loading the therapy management checklist…
Storage and cold chain
Crovalimab: storage and handling
- Refrigerate
- Yes, as the label states
Label statement
Store refrigerated at 2°C to 8°C (36°F to 46°F) in the outer carton to protect from light.
- Freezing
- Do not freeze
Label statement
Do not freeze.
- Room temperature
- up to 7 days at or below 30°C (86°F)
Label statement
Once removed from the refrigerator, the unopened vial can be kept at room temperature up to 30°C (86°F) in its outer carton for no longer than 7 days.
- Room temperature
- up to 7 days at or below 30°C (86°F)
Label statement
The total combined time out of refrigeration should not exceed 7 days and the temperature should not exceed 30°C (86°F).
- Room temperature
- up to 7 days
Label statement
Discard if stored out of the refrigerator at room temperature for longer than 7 days.
- Back into the refrigerator
- Not addressed
- Light
- Protect from light
Label statement
Store refrigerated at 2°C to 8°C (36°F to 46°F) in the outer carton to protect from light.
- Shaking
- Do not shake
Label statement
Do not shake.
All storage statements on the label (7)
- Store refrigerated at 2°C to 8°C (36°F to 46°F) in the outer carton to protect from light.
- Do not freeze.
- Do not shake.
- Once removed from the refrigerator, the unopened vial can be kept at room temperature up to 30°C (86°F) in its outer carton for no longer than 7 days.
- Prior to administration, unopened vials of PIASKY may be stored out of the refrigerator at room temperature if needed and then returned to refrigeration.
- The total combined time out of refrigeration should not exceed 7 days and the temperature should not exceed 30°C (86°F).
- Discard if stored out of the refrigerator at room temperature for longer than 7 days.
FDA label version 3, effective November 11, 2025. DailyMed
Dosing and titration calendar
Built only from the schedules the label states (loading, titration, day schedules, cycles and weight bands). Steps the label states in words the calendar cannot place are shown, not guessed.
Loading dosing schedules…
Medicare Part D coverage
No Part D formulary in the CMS files (2026Q3) lists this drug. It may be covered under Part B or not covered.
Patient assistance
No manufacturer program page is listed for this drug yet.
Independent foundations and the full directory (checked 2026-11-06). Eligibility and amounts are set by each program; open its page for them.
For licensed clinicians. Use with clinical judgment. Statements are quoted from the FDA label; confirm against the label for the product you are using.